These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14632967)

  • 1. Effects of fenofibrate on endothelial function and cell adhesion molecules during post-prandial lipemia in hypertriglyceridemia.
    Marchesi S; Lupattelli G; Lombardini R; Roscini AR; Siepi D; Vaudo G; Pirro M; Sinzinger H; Schillaci G; Mannarino E
    J Clin Pharm Ther; 2003 Oct; 28(5):419-24. PubMed ID: 14632967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous postprandial lipoprotein responses in the metabolic syndrome, and response to fenofibrate therapy.
    Rosenson RS; Helenowski IB; Tangney CC
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):439-47. PubMed ID: 20922563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men.
    Marchesi S; Lupattelli G; Schillaci G; Pirro M; Siepi D; Roscini AR; Pasqualini L; Mannarino E
    Atherosclerosis; 2000 Dec; 153(2):397-402. PubMed ID: 11164429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artichoke juice improves endothelial function in hyperlipemia.
    Lupattelli G; Marchesi S; Lombardini R; Roscini AR; Trinca F; Gemelli F; Vaudo G; Mannarino E
    Life Sci; 2004 Dec; 76(7):775-82. PubMed ID: 15581909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia.
    Capell WH; DeSouza CA; Poirier P; Bell ML; Stauffer BL; Weil KM; Hernandez TL; Eckel RH
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):307-13. PubMed ID: 12588776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia.
    Koh KK; Han SH; Quon MJ; Yeal Ahn J; Shin EK
    Diabetes Care; 2005 Jun; 28(6):1419-24. PubMed ID: 15920062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.
    Rosenson RS; Wolff DA; Huskin AL; Helenowski IB; Rademaker AW
    Diabetes Care; 2007 Aug; 30(8):1945-51. PubMed ID: 17483155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral L-arginine administration attenuates postprandial endothelial dysfunction in young healthy males.
    Marchesi S; Lupattelli G; Siepi D; Roscini AR; Vaudo G; Sinzinger H; Mannarino E
    J Clin Pharm Ther; 2001 Oct; 26(5):343-9. PubMed ID: 11679024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.
    Rosenson RS; Huskin AL; Wolff DA; Helenowski IB; Rademaker AW
    Atherosclerosis; 2008 Jun; 198(2):381-8. PubMed ID: 18242616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of postprandial hypertriglyceridemia on vascular responses in patients with coronary artery disease: effects of ACE inhibitors and fibrates.
    Bae JH; Bassenge E; Lee HJ; Park KR; Park CG; Park KY; Lee MS; Schwemmer M
    Atherosclerosis; 2001 Sep; 158(1):165-71. PubMed ID: 11500188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states.
    Perez-Martinez P; Corella D; Shen J; Arnett DK; Yiannakouris N; Tai ES; Orho-Melander M; Tucker KL; Tsai M; Straka RJ; Province M; Kai CS; Perez-Jimenez F; Lai CQ; Lopez-Miranda J; Guillen M; Parnell LD; Borecki I; Kathiresan S; Ordovas JM
    Am J Clin Nutr; 2009 Jan; 89(1):391-9. PubMed ID: 19056598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial endothelial impairment and reduced glutathione levels in postmenopausal women.
    Siepi D; Marchesi S; Lupattelli G; Paltriccia R; Vaudo G; Pirro M; Roscini AR; Scarponi AM; Sinzinger H; Mannarino E
    Ann Nutr Metab; 2002; 46(1):32-7. PubMed ID: 11914513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles.
    Lupattelli G; Lombardini R; Schillaci G; Ciuffetti G; Marchesi S; Siepi D; Mannarino E
    Am Heart J; 2000 Sep; 140(3):521-6. PubMed ID: 10966556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fenofibrate on the level of asymmetric dimethylarginine in individuals with hypertriglyceridemia.
    Yang TL; Chen MF; Xia X; Luo BL; Li YJ
    Eur J Clin Pharmacol; 2006 Mar; 62(3):179-84. PubMed ID: 16447050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment.
    Ceriello A; Quagliaro L; Piconi L; Assaloni R; Da Ros R; Maier A; Esposito K; Giugliano D
    Diabetes; 2004 Mar; 53(3):701-10. PubMed ID: 14988255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of fenofibrate on lipid profile, endothelial dysfunction, and inflammatory markers in type 2 diabetes mellitus patients with typical and mixed dyslipidemia.
    Ghani RA; Bin Yaakob I; Wahab NA; Zainudin S; Mustafa N; Sukor N; Wan Mohamud WN; Kadir KA; Kamaruddin NA
    J Clin Lipidol; 2013; 7(5):446-53. PubMed ID: 24079286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fenofibrate on serum nitric oxide levels in patients with hypertriglyceridemia.
    Esenboga K; Çiçek ÖF; Oktay AA; Ayral PA; Gürlek A
    Adv Clin Exp Med; 2019 Jul; 28(7):931-936. PubMed ID: 31237119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants.
    Tsai AK; Steffen BT; Ordovas JM; Straka R; Zhou X; Hanson NQ; Arnett D; Tsai MY
    Transl Res; 2011 Aug; 158(2):99-105. PubMed ID: 21757154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of micronized fenofibrate on vascular endothelial function in patients with hypertriglyceridemia.
    Huang Y; Dai G; Feng Z; Lu C; Cheng B; Wang Q; Nie F; Li J
    Chin Med J (Engl); 2003 Nov; 116(11):1767-9. PubMed ID: 14642156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease.
    Zhao SP; Liu L; Cheng YC; Shishehbor MH; Liu MH; Peng DQ; Li YL
    Circulation; 2004 Aug; 110(8):915-20. PubMed ID: 15313947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.